Stocks and Investing
by (remove) : Shagun Singh
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Shagun Singh
RSSJSONXMLCSV
Wed, October 2, 2024
Thu, August 8, 2024
Tue, August 6, 2024
Fri, August 2, 2024
Wed, July 31, 2024
Fri, July 26, 2024
Thu, July 25, 2024
Fri, June 14, 2024
Tue, June 4, 2024
Thu, April 25, 2024
Thu, April 18, 2024
Mon, April 15, 2024
Fri, March 1, 2024
Thu, February 29, 2024
Fri, February 23, 2024
Thu, February 15, 2024
Wed, February 14, 2024
Fri, February 9, 2024
Mon, February 5, 2024
Thu, February 1, 2024
Wed, January 31, 2024
Thu, January 25, 2024
Tue, January 16, 2024
Fri, January 12, 2024
Thu, January 11, 2024
Fri, November 3, 2023
Mon, October 16, 2023

Shagun Singh Initiated (TNDM) at Buy and Held Target at $65 on, Oct 2nd, 2024


Published on 2024-10-28 14:36:24 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Buy and Held Target at $65 on, Oct 2nd, 2024.

Shagun has made no other calls on TNDM in the last 4 months.



There are 7 other peers that have a rating on TNDM. Out of the 7 peers that are also analyzing TNDM, 2 agree with Shagun's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Patrick Wood of "Morgan Stanley" Maintained at Hold and Held Target at $45 on, Monday, September 23rd, 2024
  • Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $39 on, Friday, August 2nd, 2024


These are the ratings of the 5 analyists that currently disagree with Shagun


  • William Plovanic of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $57 on, Thursday, August 8th, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $58 on, Monday, August 5th, 2024
  • Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $58 on, Monday, June 10th, 2024
Contributing Sources